NCT00092716View on ClinicalTrials.gov

Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)

PHASE3CompletedINTERVENTIONAL
Enrollment

655

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Hypercholesterolemia
Interventions
DRUG

MK0653, ezetimibe / Duration of Treatment: 28 weeks

DRUG

Comparator: atorvastatin / Duration of Treatment: 28 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00092716 - Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025) | Biotech Hunter | Biotech Hunter